Grown Rogue International (GRUSF) Gross Margin (2011 - 2026)
Grown Rogue International (GRUSF) posted quarterly Gross Margin of 43.23% for Q1 2026, down 382.0% year-over-year from 15.33% in Q1 2025, and down 12.4% quarter-over-quarter from 49.34% in Q4 2025.
Grown Rogue International (GRUSF) Gross Margin (2011 - 2026) Analysis & Trends
Grown Rogue International's Gross Margin history runs 13 years deep, the most recent figure standing at 43.23% for Q1 2026.
- In Q1 2026, Gross Margin fell 382.0% year-over-year to 43.23%; the TTM figure through Mar 2026 stood at 0.0% (down 4928.0% YoY), while the FY2025 annual figure was 43.62%, down 612.0% from the prior year.
- Gross Margin for Q1 2026 stood at 43.23%, down from 49.34% in the prior quarter.
- The five-year high for Gross Margin was 66.81% in Q3 2025, with the low at 0.0% in Q2 2025.
- The 5-year median for Gross Margin is 49.34% (2025), against an average of 48.77%.
- The sharpest annual moves came in 2022 and 2025: Gross Margin surged 3530 bps in 2022, then tumbled 4374 bps in 2025.
- Grown Rogue International's Gross Margin stood at 61.96% in 2022, then rose by 5 bps to 65.17% in 2023, then fell by 24 bps to 49.74% in 2024, then dropped by 1 bps to 49.34% in 2025, then slipped by 12 bps to 43.23% in 2026.
- Business Quant data shows GRUSF's Gross Margin at 43.23% in Q1 2026, 49.34% in Q4 2025, and 66.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 47.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.63% |
| Mar 31, 2026 | 43.23% |
| Dec 31, 2025 | 49.34% |
| Sep 30, 2025 | 66.81% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 47.04% |
| Dec 31, 2024 | 49.74% |
| Sep 30, 2024 | 56.11% |
| Jun 30, 2024 | 43.74% |
| Mar 31, 2024 | 48.95% |
| Dec 31, 2023 | 65.17% |
| Oct 31, 2023 | 53.95% |
| Jul 31, 2023 | 46.70% |
| Apr 30, 2023 | 43.26% |
| Jan 31, 2023 | 55.57% |
| Jan 31, 2022 | 61.96% |
| Oct 31, 2021 | 82.76% |
| Jul 31, 2021 | 73.99% |
| Apr 30, 2021 | 39.47% |
| Jan 31, 2021 | 26.65% |